Cancer
About the project
„Cervical cancer and its precursors can be well managed through cytological screening. Our goal is, among other things, to strengthen the position of Liquid Based Cytology in the screening program, to point out its undeniable advantages over conventional cytology and, during the diagnostic process itself and possibly to expand its range of diagnostic possibilities. This will allow early detection of pre-cancerous conditions thus enabling individualization of further therapeutic algorithm in the respective patients. Breast cancer is another type of cancer with increasing incidence, which, despite considerable advances in medicine, keeps taking a heavy toll. I believe that our diagnostic and scientific research activities will contribute to progress in this field of medicine as well.“
Within the scope of the project, MGA focuses on research into the two most common types of cancer in women – cervical cancer and breast cancer. By conducting research in these areas, MGA intends to put into practice new diagnostic methods benefiting the people suffering from these diseases.
Cervical cancer in Slovakia represents a serious medical as well as social problem. It is the second most commonly found cancer in women with the incidence of approximately 500 new cases per year and mortality rate of 200 to 220 women every year. The most common type of cervical cancer is the squamous cell carcinoma, followed by cervical adenocarcinoma. Other types of cervical cancers are significantly less common.
Breast cancer is the most common type of cancer in women in developed countries. It makes up as much as 18% of all cancers in women. In the US only, 227,000 new cases were reported in women and 2,000 in men in 2012. The average age is between 45-50 years of age, and between 60-65 years of age. The cause of breast cancer has not been fully explained yet.
Documents
Documents
Photographic documentation
Outputs
- Mucinózne karcinómy ovária – novinky v diagnostike z pohľadu patológa, MUDr. Tomáš Torday, Newslab, 2015; 1(1): 47-50
- Prístup slovenských žien k problematike rakoviny krčka maternice, prof. MUDr. Miroslav Borovský, CSc., NEWSLAB 2015; 1(1)
- Nádorový supresorový gén pten v hyperplázii endometria a karcinóme endometria, Šišovský V., Gbelcová H., Krajčíová Ľ., Priščáková P., Hojsíková I., Straka Ľ., Konečný M., Dolešová L., Markus J., Böhmer D., Danihel Ľ., Repiská V.
- Elementy HERV a ich funkcia v ľudskom tele, Petra PRIŠČÁKOVÁ, Helena GBELCOVÁ, Ľubica KRAJČÍOVÁ, Ivana HOJSÍKOVÁ, Vanda REPISKÁ
- Zobraziť všetky
- Gény BRCA1 A BRCA2 a ich asociácia s rizikom výskytu hereditárneho karcinómu prsníka/ovárií, Lenka DOLEŠOVÁ, Michal KONEČNÝ, Helena GBELCOVÁ, Daniel BÖHMER, Ivana HOJSÍKOVÁ, Vanda REPISKÁ
- PTEN Sequence Analysis in Endometrial Hyperplasia andEndometrial Carcinoma in Slovak Women, Gbelcová, P. Bakeš, P. PrišIáková, V. Šišovský, I. Hojsíková, Straka, M. KoneIný, J. Markus, C. W. D’Acunto, T. Ruml, D. Böhmer, Ľ. Danihel and V. Repiská
- CINtec PLUS – naše skúsenosti, MUDr. Zuzana Ďuricová, 2015; 1(1) | NEWSLAB
- Komparatívna genómová hybridizácia: úvod do metodiky, RNDr. Miroslav Tomka, PhD., RNDr. Ivana Hojsíková, NEWSLAB | 2015; 1(1)
- Malígny steroid cell tumor vaječníka, MUDr. Peter Vereš, MUDr. Pavol Janega, PhD., NEWSLAB | 2015; 1(1)
- Genetic landscape of breast cancer, strana 102 až 105, RNDr. Miroslav Tomka, PhD., NEWSLAB I 2016/2
- Malobunkový hyperkalcemický karcinóm, strana 126 až 128., MUDr. Michal Zámečník, NEWSLAB I 2016/2
- Ovariálne nádory: krátky prehľad, RNDr. Miroslav Tomka, PhD., NEWSLAB I 2017/2
- O nádoroch a protinádorovej imunite, MUDr. Pavol Janega, PhD., LABMED I 2018/12
- Incidentálna pelvická lymfangioleiomyomatóza pri karcinóme maternice. Opis prípadu a pátranie po podobných léziách v súboroch stagingových resekcií, MUDr. Michal Zámečník, NEWSLAB IX 2018/1
- Celulárny angiofibróm vulvy, MUDr. Michal Zámečník, NEWSLAB IX 2018/1
- Chorangióza placenty – postihnutie placenty nejasnej etiológie (kazuistika a prehľad súčasného poznania), MUDr. Kristína Mikuš-Kuracinová, PhD., NEWSLAB IX 2018/2
- Effect of selected pre-analytic factors on immunohistochemical analysis of estrogen receptors, progesterone receptors and cell proliferation marker Ki-67 in breast carcinomas, Mgr. Monika Bialešová, NEWSLAB X 2019/1
- O nádoroch a protinádorovj imunite, MUDr. Pavol Janega, PhD.
- Mammary leiomyomatous-type myofibroblastoma with symplastic atypia, MUDr. Michal Zámečník, Karol Macuch, Journal of Interdisciplinary Histopathology
- Lekár: Každý druhý deň u nás zomrie žena na rakovinu krčka maternice, Otakar Horák, DenníkN, strana 1-10, 2017
- Komparatívna genómová hybridizácia, RNDr. Miroslav Tomka, PhD. NEWSLAB, 2015, 1 (1)
- Ileus pri farmakoterapii chronickej hnačky, Samuel Horak, Pavol Janega, NEWSLAB, roč. 11 (1): 61 -62
- Hl’adanie optimánej cesty primárneho skríningu karcinómu krčka maternice u žien v Slovenskej republike, MUDr. Pavol Janega, PhD., RNDr. Gabriel Minárik, PhD.
- ERVW-1 gene polymorphisms related to preeclampsia, Priscakova P., Konkolova J., Petrovic R., Lipov J2, Minarik G\ Bohmer D., Repiska V., Gbelcova H., Bratisl Med J 2016, 117 (6), 340-344
- Carcinosarcoma_like endometrioid carcinoma of the uterus case report of rare non-high-grade tumor, Michal Zámečník, Jozef Kuruc, Michal Gaman, Branislav Bystrický, NEWSLAB, 2020, roč. 11 (1): 55-60
